Calleja, José-Luis <br/><br/>
Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Nov 2012 
 - 1705-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2012.07214.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Antiviral Agents--adverse effects<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Hepacivirus--genetics<br/>Hepatitis C--blood<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--adverse effects<br/>RNA, Viral--blood<br/>Recombinant Proteins--adverse effects<br/>Ribavirin--adverse effects<br/>Viral Load